Divi's Laboratories Limited (BOM:532488)
India
· Delayed Price · Currency is INR 6,551.60
-78.55 (-1.18%)
At close: Jun 6, 2025
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| Active Pharmaceutical Ingredients and Intermediates | 78.45B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Active Pharmaceutical Ingredients and Intermediates Growth | 1.00% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
| Europe | 30.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | -4.75% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 10.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | -43.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Switzerland | 10.25B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 10.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | -2.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India | 9.84B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| India Growth | 0.86% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas | 3.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Americas Growth | 4.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World | 3.51B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of the World Growth | 0.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|